CIK 0001388320
- Non-accelerated filer
- Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880378336
- Phone
- +1 646-677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 4 Open-market sale 10% owner sold 9,468 shares at an average $1.72 ($16,287)
- 4 Open-market sale 10% owner sold 3,100 shares at an average $1.80 ($5,581)
- 4 Open-market sale 10% owner sold 21,990 shares at $1.80 ($39,582)
- 4 Open-market sale 10% owner sold 20,840 shares at an average $1.81 ($37,762)
- 4 Open-market sale 10% owner sold 148,100 shares at an average $1.81 ($268,436)
- 4 Open-market sale 10% owner sold 33,619 shares at $1.90 ($63,876)
- 4 Open-market sale 10% owner sold 17,790 shares at an average $2.01 ($35,716)
- 4 Open-market sale 10% owner sold 169,450 shares at an average $1.97 ($333,385)
- 4 Open-market sale 10% owner sold 40,068 shares at an average $1.92 ($77,061)
- 4 Open-market sale 10% owner sold 36,400 shares at an average $1.90 ($69,236)
- 4 Open-market sale 10% owner sold 52,577 shares at an average $2.04 ($107,265)
- 4 Open-market sale 10% owner sold 196,497 shares at an average $2.03 ($398,919)
- 4 Open-market buy Director bought 5,000 shares at $2.00 ($10,000)
- 4 Open-market buy CEO and Interim CFO bought 10,000 shares at an average $2.02 ($20,180)
- 4 Open-market buy Director bought 15,000 shares at an average $1.99 ($29,900)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,500 shares at $2.01 ($5,025)
- 4 Open-market buy Director bought 3,000 shares at $2.02 ($6,060)
- 4 Returned to the company President, CEO and Interim CFO returned 120,501 shares (to the company)
- 4 Returned to the company COO and Chief Medical Officer returned 2,380 shares (to the company)
Page 6 of 8 · 146 filings